| 0.9% SODIUM CHLORIDE SOLUTION CHLORIDE FOR INFUSION B. BRAUN | SODIUM CHLORIDE | 2014/23.2.1/4869 | 05/02/2014 | 12/31/2027 | SOLUTION | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 6G/1000 ML | B. BRAUN MEDICAL (PTY) LTD; B.BRAUN MELSUNGEN AG; B. BRAUN MEDICAL; B. BRAUN MEDICAL; B. BRAUN MELSUNGEN AG; | B. BRAUN MEDICAL (PTY) LTD | B. BRAUN MEDICAL (PTY) LTD |
| 4CS CHILDRENS COUGH AND COLD SYRUP | DEXTROMETHORPHAN; CHLORPHENIRAMINE MALEATE; PARACETAMOL; PHENYLEPHRINE HYDROCHLORIDE | 76/22.5.5/624 | 05/05/1976 | 12/31/2027 | SYRUP; ORAL | PHARMACY MEDICINES (P.) | 0.5; 2; 120; 2.5MG | CAPS PVT LTD; | CAPS PVT LTD | CAPS PVT LTD |
| 5D | GLUCOSE | 2016/23.2.1/5251 | 09/06/2016 | 12/31/2027 | SOLUTION | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 50G | OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED; | GRANITESIDE CHEMICALS (PVT) LTD | OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED |
| 5-FLUOROURACIL SANDOZ | 5-FLOUROURACIL | 2023/9.2.1/6479 | 09/20/2023 | 09/20/2028 | SOLUTION; INJECTION | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 500 MG/10ML | FAREVA UNTERACH GMBH; | SANDOZ SA (PTY) | SANDOZ GMBH |
| 5-FLUOROURACIL SANDOZ | 5-FLOUROURACIL | 2023/9.2.1/6480 | 09/20/2023 | 09/20/2028 | SOLUTION; INJECTION | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 1 G/20ML | FAREVA UNTERACH GMBH; | SANDOZ SA (PTY) | SANDOZ GMBH |
| ABACAVIR | ABACAVIR | 2015/7.13/5015 | 04/16/2015 | 12/31/2027 | TABLET, COATED; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 300MG | AUROBINDO PHARMA LTD; | AUROBINDO PHARMA LIMITED | AUROBINDO PHARMA LIMITED |
| ABACAVIR SULFATE; LAMIVUDINE | ABACAVIR SULFATE; LAMIVUDINE | 2018/7.13/5521 | 01/11/2018 | 12/31/2027 | TABLET, COATED; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 600; 300MG | AUROBINDO PHARMA LIMITED; | AUROBINDO PHARMA LIMITED | AUROBINDO PHARMA LIMITED |
| ABACAVIR SULFATE; LAMIVUDINE | ABACAVIR SULFATE; LAMIVUDINE | 2018/7.13/5589 | 03/15/2018 | 12/31/2027 | TABLET; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 120; 60MG | MYLAN LAB LTD; | MYLAN LABORATORIES LIMITED | MYLAN LABORATORIES LIMITED |
| ABACAVIR SULPHATE | ABACAVIR SULPHATE | 2015/7.13/5082 | 09/21/2015 | 12/31/2027 | SOLUTION | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 20 MG/ML | HETERO DRUGS LTD; | HETERO LABS LTD | HETERO LABS LTD |
| ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | 2021/7.13/6216 | 12/15/2021 | 12/31/2027 | TABLET, COATED; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 600; 50; 300MG | LAURUS LABS LIMITED; | LAURUS LABS LIMITED | LAURUS LABS LIMITED |
| ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE | 2022/7.13/6279 | 04/07/2022 | 12/31/2027 | TABLET, COATED; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 600; 50; 300 MG | HETERO LABS LIMITED; | HETERO LABS LTD | HETERO LABS LTD |
| ABACAVIR SULPHATE; LAMIVUDINE | ABACAVIR SULPHATE; LAMIVUDINE | 2015/7.13/4973 | 01/20/2015 | 12/31/2027 | TABLET; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 600; 300MG | MYLAN LABORATORIES LTD; MYLAN LABORATORIES LIMITED; | MYLAN LABORATORIES LIMITED | MYLAN LABORATORIES LIMITED |
| ABACAVIR SULPHATE; LAMIVUDINE | ABACAVIR SULPHATE; LAMIVUDINE | 2015/7.13/5083 | 09/07/2015 | 12/31/2027 | TABLET, COATED; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 600; 300MG | HETERO LABS LTD,; | HETERO LABS LTD | HETERO LABS LTD |
| ABACAVIR SULPHATE; LAMIVUDINE | ABACAVIR SULPHATE; LAMIVUDINE | 2021/7.13/6121 | 04/29/2021 | 12/31/2027 | TABLET, COATED; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 120; 60MG | CIPLA LTD; | CIPLA LTD | CIPLA LTD |
| ABACAVIR SULPHATE; LAMIVUDINE | ABACAVIR SULFATE; LAMIVUDINE | 2019/7.13/5941 | 11/08/2019 | 12/31/2027 | TABLET, COATED; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 600; 300MG | SUN PHARMACEUTICAL INDUSTRIES LIMITED; | SUN PHARMACEUTICAL INDUSTRIES LIMITED | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| ABACAVIR SULPHATE; LAMIVUDINE | ABACAVIR SULPHATE; LAMIVUDINE | 2024/7.13/6562 | 01/31/2024 | | TABLET; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 120; 60MG | CIPLA LIMITED; | CIPLA LTD | CIPLA LTD |
| ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE | ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE | 2019/7.13/5944 | 11/27/2019 | 12/31/2027 | TABLET, COATED; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 600; 50; 300MG | CIPLA LTD; | CIPLA LTD | CIPLA LTD |
| ABACAVIR; LAMIVUDINE | ABACAVIR; LAMIVUDINE | 2024/7.13/6629 | 06/06/2024 | 12/31/2027 | TABLET, COATED; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 600; 300MG | LAURUS LABS LIMITED; | LAURUS LABS LIMITED | LAURUS LABS LIMITED |
| ABAMAT TABLETS | ABACAVIR SULPHATE | 2008/7.13/4535 | 07/07/2008 | 12/31/2027 | TABLET, COATED; ORAL | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 300MG | MYLAN LABORATORIES LTD; MYLAN LABORATORIES LIMITED; | MYLAN LABORATORIES LIMITED | MYLAN LABORATORIES LIMITED |
| ABEVMY - 100 | BEVACIZUMAB | 2021/9.7/6140 | 06/14/2021 | 12/31/2027 | INJECTABLE; INJECTION | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | 100MG / 4ML | BIOCON LIMITED; | BIOSIMILARS NEWCO LIMITED | BIOSIMILARS NEWCO LIMITED |